Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest phases of cell line development. read more
An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
Monday, August 03, 2026
Polpharma Biologics announced that the FDA and the EMA have accepted for review the Biologics License Application (BLA) and Marketing Authorization ... read more
Codis Completes Nottingham Deal to Expand Europe’s Spray Dry Network
Monday, August 03, 2026
Codis has completed its acquisition of Catalent’s Nottingham, UK facility, a move that expands the company’s integrated spray dry offering in Europe ... read more
Genezen, Raiden Science Foundation Partner on UBA5 Gene Therapy Manufacturing
Monday, August 03, 2026
Genezen and the Raiden Science Foundation have announced a manufacturing partnership for an AAV9 gene replacement therapy for UBA5 disorder, moving ... read more
Resilience and Lilly Invest $750M to Increase U.S.-Manufactured Medicine Supply
Monday, August 03, 2026
Resilience announced it has expanded its strategic partnership with Eli Lilly and Company to increase U.S. production of critical medicines featuring ... read more
Cellipont Bioservices Announces Release of 100th GMP Batch
Thursday, July 30, 2026
Cellipont Bioservices announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas. read more